Drug Database
J05AR03 tenofovir disoproxil and emtricitabine
Approved by UK Medicines & Healthcare Products Regulatory Agency & the European Medicines Agency.
- POM Emtricitabin/Tenofovirdisoproxil Amarox 200 mg/245 mg film-coated tablets
- POM Emtricitabine/Tenofovir disoproxil 200 mg/245 mg film-coated tablets
- POM Emtricitabine/Tenofovir disoproxil 200mg/245mg film-coated Tablets
- POM Emtricitabine/Tenofovir disoproxil Dr. Reddy's 200 mg/245 mg Film-Coated Tablets
- POM Emtricitabine/Tenofovir disoproxil Glenmark 200 mg/245 mg Film-coated Tablets
- POM Emtricitabine/Tenofovir disoproxil Lupin 200 mg/245 mg Film-coated Tablets
- POM Emtricitabine/Tenofovir disoproxil Milpharm 200 mg/245 mg Film-coated Tablets
- POM Emtricitabine/Tenofovir disoproxil Mylan 200 mg/245 mg film coated tablets
- POM Emtricitabine/Tenofovir disoproxil Tillomed 200 mg/245 mg film-coated tablets
- POM Emtricitabine/Tenofovir disoproxil Zentiva 200 mg / 245 mg film-coated tablets
- POM Ictastan 200mg/245mg Film-coated Tablets
Learning Zones
Disclaimer
The drug SPC information (indications, contra-indications, interactions, etc), has been developed in collaboration with eMC (www.medicines.org.uk/emc/). Medthority offers the whole library of SPC documents from eMC.
Medthority will not be held liable for explicit or implicit errors, or missing data.
Drug Licencing
Drugs appearing in this section are approved by UK Medicines & Healthcare Products Regulatory Agency (MHRA), & the European Medicines Agency (EMA).